(Q74772266)
English
Angiotensin-converting enzyme gene polymorphism determines the antiproteinuric and systemic hemodynamic effect of enalapril in patients with proteinuric renal disease. Austrian Study Group of the Effects of Enalapril Treatment in Proteinuric Renal D
scientific article published on 01 January 1998
Statements
Angiotensin-converting enzyme gene polymorphism determines the antiproteinuric and systemic hemodynamic effect of enalapril in patients with proteinuric renal disease. Austrian Study Group of the Effects of Enalapril Treatment in Proteinuric Renal Disease (English)
M Haas
N Yilmaz
A Schmidt
U Neyer
K Arneitz
H K Stummvoll
M Wallner
M Auinger
I Arias
1 January 1998